Catalyst Wire Dossier Catalyst Wire Dossier

MYDAYIS

mixed amphetamine salts, extended-release
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for MYDAYIS, covering 2017-06-20 to 2026-04-23. Get the full timeline:

Most recent: FDA Approved: MYDAYIS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

See pricing